Twitter

Posts Tagged ‘sponsor’


Cancer cause launches its Valentine’s appeal

The Eric Wright Group based in Leyland has announced it will be the main sponsor for the Rosemere Cancer Foundation’s Valentine’s Appeal 2013.

Read More...

Lions cancer walk set for June 2

The Hammonton Lions Club will sponsor a cancer walk from 9 a.m. to noon on June 2 on Hammonton Middle School’s field track on Liberty Street.

Read More...

Efficacy and Safety of CO2 vs Room Air Insufflation During Colonoscopy or ESD for Gastric Tumor

Condition :   Gastric Tumor Intervention :   Procedure: CO2 or room air insufflation during colonoscopy or ESD for gastric tumor Sponsor :   Gachon University Gil Medical Center Not yet recruiting – verified April 2012

Read More...

LACRIMAL DRAINAGE SYSTEM OBSTRUCTION ASSOCIATED TO RADIOACTIVE IODINE THERAPY FOR THYROID CARCINOMA

Condition :   Lacrimal Apparatus Disease Intervention :   Sponsor :   Fabricio Lopes da Fonseca Enrolling by invitation – verified April 2012

Read More...

Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

Conditions :   Lung Adenocarcinoma;   Brain Metastases Interventions :   Drug: erlotinib;   Drug: pemetrexed;   Drug: cisplatin;   Drug: erlotinib Sponsor :   Guangzhou Medical College Recruiting – verified April 2012

Read More...

Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel

Condition :   Cancer Intervention :   Drug: SOR-C13 Sponsor :   Soricimed Biopharma Inc Not yet recruiting – verified April 2012

Read More...

Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C

Condition :   Advanced Gastrointestinal Malignancies Intervention :   Drug: MLN0264 Sponsor :   Millennium Pharmaceuticals, Inc. Not yet recruiting – verified April 2012

Read More...

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors

Condition :   Solid Tumors Intervention :   Biological: MEDI0639 Sponsor :   MedImmune LLC Recruiting – verified April 2012

Read More...

Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer

Condition :   Non Small Cell Lung Cancer Interventions :   Drug: EC145;   Drug: EC145 + Docetaxel;   Drug: Docetaxel;   Drug: EC20 Sponsor :   Endocyte Recruiting – verified April 2012

Read More...

Tumor Markers in Lung Cancer: DCAMLK-1LK-1

Conditions :   Lung Cancer;   Smoking Interventions :   Other: Measure DCAM levels in blood;   Other: DCAM levels in blood Sponsor :   University of Oklahoma Recruiting – verified April 2012

Read More...